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Surveys reviewed for WUENIC in 7 countries, 2008–2015, children aged 12
Country Year of WUENIC Year of Survey
Afghanistan 2012 2013
2010 2010–11
Cote d’Ivoire 2014 2015
2013 2014
2012 2013
2011 2011–12
Central African 2011 2012
Republic 2009 2010
Democratic 2012 2013–14
Republic of Congo 2011 2012
2009 2010
Mali 2011 2012–13
2009 2010
2008 2009–10
Nigeria 2012 2013
2010 2011
2009 2010
2007 2008
Pakistan 2013 2014–15
2012 2012–13
2012 2013–14
2010 2010–11
2007 2008–9
WUENIC: WHO/UNICEF Estimates of National Immunization Coverage.
DTP3: third dose of diphtheria-tetanus-pertussis vaccine (results are for c
EPI: Expanded Programme on Immunization.
MICS: UNICEF Multiple Indicator Cluster Survey.
DHS: Demographic and Health Survey.
PSLM: Pakistan Social and Living Standards Measurement Survey.
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This is an open access article under the CC BY license (http://creativecommDear Editor,
We thank Pond and Mounier-Jack for their comments on our
paper, ‘‘Monitoring vaccination coverage: Defining the role of
surveys” [1]. We agree that for many countries, administrative
estimates of coverage are greatly inflated and misleading for pro-
gramme planning purposes. The robustness of the WHO-UNICEF
estimates of national immunization coverage (WUENIC) depends
on the quality of the underlying data reviewed, which include
administrative reports, as well as probability and non-probability
sample surveys. In 2012, the Grade of Confidence (GoC) was intro-
duced as a means of conveying uncertainty in WUENIC [2] and is
low in the seven conflict-affected countries listed by Pond and
Mounier-Jack. Table 1 shows that in five of these countries,–23 months.
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hildren aged 1
ons.org/licensevaccination cards were available for less than half the children sur-
veyed; when card availability is low, it is particularly difficult to
compare coverage trends. For example, in Nigeria, the proportion
of children with DTP3 according to card was similar in surveys in
2010, 2011 and 2013, but in the EPI survey of 2010 a verbal history
of vaccination was reported for 43% of children, more than double
that of previous or subsequent surveys. Elsewhere, results from
surveys did not always match expected trends (e.g. no apparent
fall in coverage between surveys despite a 7 month stockout of
DTP in one country), and some results were very unlikely (e.g. zero
dropout between DTP1 and DTP3 in one Multiple Indicator Cluster
Survey (MICS) (data from country reports at http://apps.who.int/
immunization_monitoring/globalsummary/wucoveragecountrylist.
html)).
The updated WHO guidelines on vaccination coverage surveys
(http://www.who.int/immunization/monitoring_surveillance/
Vaccination_coverage_cluster_survey_with_annexes.pdf) discusstype % cards DTP3% by card DTP3%
History
DTP3%
Total
66 54 6 60
31 32 9 41
iew 91 70 6 76
A 75 61 11 82
88 78 4 82
74 56 8 64
50 41 6 47
32 16 16 32
26 24 36 60
35 21 56 77
43 37 25 62
38 29 34 63
59 49 23 72
65 47 28 75
28 22 16 38
24 26 18 45
40 25 43 68
26 20 15 35
n/a 65 23 88
36 32 33 65
n/a 61 20 81
n/a 56 19 85
n/a 51 33 84
2–23 months).
s/by/4.0/).
Reply to Letter to the Editor / Vaccine 34 (2016) 6112–6113 6113the challenges of using a new survey to compare with an older
one, particularly an immunization coverage survey – these often
lacked information on likely biases and confidence intervals were
either not reported or not very meaningful from non-probability
samples. The best way to compare results from different surveys
is to plan a pair of surveys for such a purpose and work very hard
to ensure standardised, well-documented and high quality data
collection in both. Pond and Mounier-Jack suggest that two such
surveys are feasible within each 5 years period. We would be
reluctant to stipulate any particular interval as the usefulness of
repeat surveys will depend in part on the likelihood of a change
in coverage having occurred (which can be predicted from
monitoring other indicators) [1] and the availability of accurate
documentation of vaccination status on home-based or clinic
records. Most of all, surveys should lead to action to strengthen
programme performance and this is likely the weakest link in
many countries, including those affected by conflict.
We also question whether frequent conduct of high-quality sur-
veys is always the best investment, particularly when countries
may not use results to improve EPI performance. In the Americas,
strong progress towards programme goals has been attributed to
technical oversight, partnership and coordination to strengthen
routine information systems and the continuous monitoring of
administrative data (including numerators separate from denomi-
nators), surveillance and public health laboratory networks, as well
as pooled vaccine purchase [3,4]. The Pan American Health Organi-
zation (PAHO) rarely recommended or funded surveys [4].
We encourage the global community to continue its support to
improve monitoring systems as well as surveys, while building-up
the evidence regarding the best uses of vaccination coverage sur-
veys and other monitoring tools, without losing focus on the actual
implementation of strategies proven to improve immunization
programme performance.
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